Customize Your Learning Experience!

Mix-and-match sessions from these additional co-located conferences at no additional cost:

• Process & Product Validation
• Technology Transfer for Biopharmaceuticals
• Outsourcing Manufacturing of Biopharmaceuticals
• Biopharmaceutical Raw Materials throughout the Product Lifecycle

Stay for the week so you can attend on Feb. 29 - March 2 for these conferences:

• Antibody Development & Production
• Recombinant Protein & Complex Biologic Development & Production
• Analytical Technologies for Biotherapeutic Development
• Biobetters & Biosimilars: Technologies & Development Strategies

Get the Most Out of Your Budget with the "All Access Pass" to Attend Sessions from All 9 Conferences

View the Agenda-at-a-Glance for the Entire Week.

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until February 3, 2012.
To book your room, call 1-800-HILTONS and mention that you are an IBC attendee at this event.

Get Up To Date Event Information

Join our priority contact list and receive the latest event news.

Recent adventitious agent incidents have resulted in increased regulatory scrutiny and the need for new technologies and risk mitigation strategies to detect, prevent and remediate viral contaminations in raw materials, cell culture processes and facilities throughout the entire supply chain.

Attend this conference to learn about:

• Risk-based measures and strategies for mAbs, proteins and vaccine products
• Novel strategies and technologies to establish effective viral barriers: How to detect adventitious agents we don't know about?
• Nanofiltration and pre-filtration: new technologies, validation and regulatory guidance
• Virus spike and ultrapure virus preparations: What is the process and regulatory impact?
• Contamination case studies and facility protection strategies: lessons learned, corrective actions
• Cell banks, cell lines, cell substrates and media: Is there value in raw material testing?

Featured Presentations

MMV Contamination: Detection, Root Cause Determination, and Corrective Actions
Mark D. Moody, Ph.D.
Vice President of Analytical Services
Merrimack Pharmaceuticals

Intelligent Process Design for Reducing Parvovirus Filter Costs
Jerome Bill Jr.
Engineer II, Purification Development
Genentech, Inc.

Applying a Risk-based Product Protection Strategy to a New Mammalian Cell Culture Bioprocessing Facility
Marie Murphy, Ph.D.
Microbiologist, Biotechnology Operations
Eli Lilly, Ireland

Testing Raw Materials for Adventitious Agents Prior to Use in Manufacturing
Sridhar Pennathur, Ph.D.
Senior Director, Biosafety Testing, Department of Quality Control
MedImmune, Inc.